Jacobs Levy Equity Management’s Vyant Bio VYNT Stock Holding History
Bought
Maintained
Sold
Other funds holding VYNT
Jacobs Levy Equity Management's VYNT Position: Q2 2018 in Review
Jacobs Levy Equity Management sold out of Vyant Bio (VYNT) in Q2 2018, closing a stake of 110 shares — an estimated $27K sold.
Jacobs Levy Equity Management first reported a position in VYNT in Q4 2016 and held it in 6 quarters. The position peaked at $165K in Q1 2017. 23 funds tracked by Wall St. Rank hold VYNT as of Q2 2018.
- Jacobs Levy Equity Management reported no remaining Vyant Bio position as of Q2 2018 after selling out during the quarter.
- Jacobs Levy Equity Management sold 110 Vyant Bio shares in Q2 2018, an estimated $27K.
- Jacobs Levy Equity Management first reported a position in Vyant Bio in Q4 2016 and held it in 6 quarters.
- Jacobs Levy Equity Management's Vyant Bio position peaked at $165K in Q1 2017.
- 23 funds tracked by Wall St. Rank held Vyant Bio as of Q2 2018.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.